Introduction
The occurrence of pacemaker-related malfunction resulting from firmware updates is rare. The estimated risk of reloading of previous firmware due to incomplete update is 0.161%, loss of programmer device settings is 0.023%, and complete loss of device functionality is 0.003%, as informed by the manufacturer. 1 Recently, Abbott Medical released a software patch that updates firmware to patch cybersecurity vulnerabilities. Because to date there have been no known instances of successful hacking of a pacemaker system or instances of clinical harm, the risk associated with a firmware update must be balanced against the theoretical risk of a cybersecurity vulnerability. Here we report the occurrence of malfunctions encountered during pacemaker interrogation of 3 Abbott pacemakers associated with the version 23.1.1 Abbott firmware update. The firmware update affected programmers, wireless pacemakers, and Merlin.Net remote monitoring devices, and was designed to address cybersecurity and premature battery depletion issues. 1 
Case reports Case 1
An 85-year-old man with pacemaker dependency because of high-grade atrioventricular block had received a dualchamber Accent DR RF pacemaker (Abbott Laboratories, Abbott Park, IL) programmed DDDR. During routine pacemaker interrogation with the programmer (model 3650) loaded with version 23.1.1 software, the device cybersecurity update prompt appeared, and the update was initiated. During the cybersecurity update process, a 4-second pause occurred before the resumption of pacing and was associated with lightheadedness in the patient. After completion of the 5-minute cybersecurity update, an attempt to export the interrogation data failed because of an error (Figure 1 ). The programmer was rebooted, and the battery current on the pacemaker was noted to have increased from 11 to 27 mA, with a concomitant drop in the lower limit of battery longevity (Figure 2 ).
Case 2
A 74-year-old man with a history of symptomatic sinus bradycardia who had received a dual-chamber Accent DR RF pacemaker (Abbott Laboratories) programmed DDDR underwent pacemaker interrogation before magnetic resonance imaging for planned prostate cancer radiotherapy. Initial interrogation with the programmer (model 3650) loaded with version 23.1.1 software only yielded error codes ( Figure 3A) . Only a telemetry wand was used during the interrogation, as opposed to a wand with radiofrequency tower, and both the wand and the patient were in complete stationary positions. Another interrogation attempted with a programmer (model 3650) loaded with version 22.1.1 software permitted interrogation of the pacemaker. However, an error code appeared when programming was attempted ( Figure 3B ). Uninterpretable characters appeared in the patient data fields on the programming screen, suggesting malfunction ( Figure 3C ). Because of safety concerns, magnetic resonance imaging was canceled and rescheduled. Eventually, with the assistance of the device manufacturer engineering team, a software patch was programmed, which then permitted pacemaker programming. The patient's pacemaker was found to be programmed to DOO at 60 bpm,
KEY TEACHING POINTS
It is important to exercise caution when performing pacemaker interrogations after new firmware updates, especially in pacemaker-dependent patients.
Risk versus benefit of performing a firmware update should be discussed with the patient.
A practical strategy after release of new firmware updates may be to initiate firmware updates first in nondependent patients until the safety of firmware updates is well established.
even though the original mode was DDDR. The original settings were restored.
Case 3
A 77-year-old man with a history of symptomatic sinus bradycardia who had received a dual-chamber Accent DR RF pacemaker (Abbott Laboratories) programmed DDDR underwent a routine pacemaker interrogation to evaluate suspected ventricular tachycardia episodes. The pacemaker had not been updated with the version 23.1.1 firmware patch. Interrogation with a programmer (model 3650) loaded with version 23.1.1 software resulted in only error codes being presented on the programmer screen. The manufacturer's engineering team provided a software patch, which ultimately permitted communication between the programmer and the device. Some garbled data had to be retyped.
Discussion
We report 3 cases of software malfunction encountered within the same week that were associated with the version 23.1.1 firmware patch update. The version 23.1.1 firmware patch update is part of Abbott's efforts to enhance cybersecurity, especially to address the risk of unauthorized programming of implantable devices. Because of online delivery to Web servers of patient physiological and device data along with near-field communication capabilities, recent cardiac implantable electronic devices (CIEDs) have increased vulnerability to cybersecurity threats. 2 Firmware is permanently embedded software programmed into ROM that provides low-level device-specific hardware control. In contrast, software provides operational instructions to applications on the device. Firmware changes are rarely performed during the lifetime of a device, whereas software updates are not infrequent. Because of CIED longevity, older operating systems that lack modern encryption are still in clinical use, potentially exposing patients to cybersecurity threats. All CIEDs at this time download device self-testing and measurements along with data on arrhythmia episodes, but programming, if needed, still requires an in-office visit.
The manufacturer states that data encryption, operating system patches, network connectivity controls, and firmware updates are all part of the recent patch designed to be delivered to the device during in-office visits. However, potential conflict between existing firmware and the current update may rarely lead to data corruption and/or device malfunction. The estimated risk of malfunction after a firmware update ranges from a 0.003% risk of loss of device functionality to a 0.023% risk of loss of programmed device settings. 1 Our first case demonstrated a malfunction that occurred during a firmware update, during which a 4-second pause occurred. It indicates a transient loss of device pacing function that could pose a risk to patients who are pacemaker dependent. Subsequently, a change in device battery current was noted. During the firmware update, intracardiac electrograms are not available, and the device operates in a backup mode with unipolar pacing with VVI mode at 67 bpm. Given this experience, it would be important to practice caution in performing a firmware update in pacemaker-dependent patients. Our second and third cases both demonstrated that errors and corruption of data can occur when interrogating a pacemaker using version 22.1.1 software with a programmer loaded with version 23.1.1. A potential cause of the error is disruption in the connection between the programmer and the pacemaker. In both cases, a telemetry wand was used and maintained in place at the patient's chest throughout the interrogation, suggesting that the disruption was not due to a radiofrequency communication range error. There were also no obvious environmental factors that may have led to a disruption in communication. The Accent DR RF pacemaker was involved in all 3 cases, and this may reflect potential errors when updating older pacemaker models or interrogating older pacemaker models with newer programmers.
Conclusion
This experience highlights the importance of exercising caution when performing pacemaker interrogations after new firmware updates if the programmer and implant software versions mismatch and when updating firmware, especially in pacemaker-dependent patients with older pacemaker models. A practical strategy after release of new firmware updates may be to initiate firmware updates first in nondependent patients until the safety of the firmware updates is well established. Additionally, it may be prudent to offer pacemaker-dependent patients the update in hospital surroundings where temporary transvenous pacing is readily available. In patients close to activation of the elective replacement indicator the update may be deferred altogether given that new devices are preloaded with updated software. Pre-update precautions will incorporate a full device check that includes unipolar pacing, printing or digitally storage of programmed device settings and diagnostic data in case of loss of data during update, surface leads connected with paper running, and utilization of wand alone with disconnection of radiofrequency. Most importantly, the risk vs benefit of performing a firmware update for a possible but as yet unrealized malicious cybersecurity attack should be discussed with the patient. Although software and firmware updates are unavoidable, it is reasonable to make a clinical judgment regarding the essential nature of the recommended update to determine the appropriate timing and location to perform the update. If the update is geared toward preventing a potential cybersecurity threat, most patients may not need the update immediately, especially given its attendant risks.
